cd38 inhibitor and 5-amino-1mq synergy nad+ CD38-expressing macrophages drive age-related decline Heavy-chain antibody targeting of CD38
Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports Inhibition of CD38 enzymatic activity enhances CAR T cell immune therapeutic efficacy by repressing glycolytic metabolism ScienceDirect Inhibition of CD38 by 78c Enhanced NAD+, Alleviated Inflammation, and Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens CD38 connects the heart and brain Translational Psychiatry CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




